Copyright Reports & Markets. All rights reserved.

Global Subcutaneous Immunotherapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Subcutaneous Immunotherapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Asthma
      • 1.4.3 Allergic Rhinitis
      • 1.4.4 Venom Allergy
      • 1.4.5 Food Allergy
    • 1.5 Market by Application
      • 1.5.1 Global Subcutaneous Immunotherapy Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Online Pharmacies
      • 1.5.4 Retail Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Subcutaneous Immunotherapy Market Size
    • 2.2 Subcutaneous Immunotherapy Growth Trends by Regions
      • 2.2.1 Subcutaneous Immunotherapy Market Size by Regions (2014-2025)
      • 2.2.2 Subcutaneous Immunotherapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Subcutaneous Immunotherapy Market Size by Manufacturers
      • 3.1.1 Global Subcutaneous Immunotherapy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Subcutaneous Immunotherapy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Subcutaneous Immunotherapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Subcutaneous Immunotherapy Key Players Head office and Area Served
    • 3.3 Key Players Subcutaneous Immunotherapy Product/Solution/Service
    • 3.4 Date of Enter into Subcutaneous Immunotherapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Subcutaneous Immunotherapy Market Size by Type (2014-2019)
    • 4.2 Global Subcutaneous Immunotherapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Subcutaneous Immunotherapy Market Size (2014-2019)
    • 5.2 Subcutaneous Immunotherapy Key Players in United States
    • 5.3 United States Subcutaneous Immunotherapy Market Size by Type
    • 5.4 United States Subcutaneous Immunotherapy Market Size by Application

    6 Europe

    • 6.1 Europe Subcutaneous Immunotherapy Market Size (2014-2019)
    • 6.2 Subcutaneous Immunotherapy Key Players in Europe
    • 6.3 Europe Subcutaneous Immunotherapy Market Size by Type
    • 6.4 Europe Subcutaneous Immunotherapy Market Size by Application

    7 China

    • 7.1 China Subcutaneous Immunotherapy Market Size (2014-2019)
    • 7.2 Subcutaneous Immunotherapy Key Players in China
    • 7.3 China Subcutaneous Immunotherapy Market Size by Type
    • 7.4 China Subcutaneous Immunotherapy Market Size by Application

    8 Japan

    • 8.1 Japan Subcutaneous Immunotherapy Market Size (2014-2019)
    • 8.2 Subcutaneous Immunotherapy Key Players in Japan
    • 8.3 Japan Subcutaneous Immunotherapy Market Size by Type
    • 8.4 Japan Subcutaneous Immunotherapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Subcutaneous Immunotherapy Market Size (2014-2019)
    • 9.2 Subcutaneous Immunotherapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Subcutaneous Immunotherapy Market Size by Type
    • 9.4 Southeast Asia Subcutaneous Immunotherapy Market Size by Application

    10 India

    • 10.1 India Subcutaneous Immunotherapy Market Size (2014-2019)
    • 10.2 Subcutaneous Immunotherapy Key Players in India
    • 10.3 India Subcutaneous Immunotherapy Market Size by Type
    • 10.4 India Subcutaneous Immunotherapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Subcutaneous Immunotherapy Market Size (2014-2019)
    • 11.2 Subcutaneous Immunotherapy Key Players in Central & South America
    • 11.3 Central & South America Subcutaneous Immunotherapy Market Size by Type
    • 11.4 Central & South America Subcutaneous Immunotherapy Market Size by Application

    12 International Players Profiles

    • 12.1 Anergis
      • 12.1.1 Anergis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Subcutaneous Immunotherapy Introduction
      • 12.1.4 Anergis Revenue in Subcutaneous Immunotherapy Business (2014-2019)
      • 12.1.5 Anergis Recent Development
    • 12.2 HAL Allergy Group
      • 12.2.1 HAL Allergy Group Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Subcutaneous Immunotherapy Introduction
      • 12.2.4 HAL Allergy Group Revenue in Subcutaneous Immunotherapy Business (2014-2019)
      • 12.2.5 HAL Allergy Group Recent Development
    • 12.3 Merck
      • 12.3.1 Merck Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Subcutaneous Immunotherapy Introduction
      • 12.3.4 Merck Revenue in Subcutaneous Immunotherapy Business (2014-2019)
      • 12.3.5 Merck Recent Development
    • 12.4 Allergy Therapeutics
      • 12.4.1 Allergy Therapeutics Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Subcutaneous Immunotherapy Introduction
      • 12.4.4 Allergy Therapeutics Revenue in Subcutaneous Immunotherapy Business (2014-2019)
      • 12.4.5 Allergy Therapeutics Recent Development
    • 12.5 ALK-Abello
      • 12.5.1 ALK-Abello Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Subcutaneous Immunotherapy Introduction
      • 12.5.4 ALK-Abello Revenue in Subcutaneous Immunotherapy Business (2014-2019)
      • 12.5.5 ALK-Abello Recent Development
    • 12.6 Stallergenes Greer
      • 12.6.1 Stallergenes Greer Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Subcutaneous Immunotherapy Introduction
      • 12.6.4 Stallergenes Greer Revenue in Subcutaneous Immunotherapy Business (2014-2019)
      • 12.6.5 Stallergenes Greer Recent Development
    • 12.7 Laboratorios LETI
      • 12.7.1 Laboratorios LETI Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Subcutaneous Immunotherapy Introduction
      • 12.7.4 Laboratorios LETI Revenue in Subcutaneous Immunotherapy Business (2014-2019)
      • 12.7.5 Laboratorios LETI Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.
      In 2018, the global Subcutaneous Immunotherapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Subcutaneous Immunotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Subcutaneous Immunotherapy development in United States, Europe and China.

      The key players covered in this study
      Anergis
      HAL Allergy Group
      Merck
      Allergy Therapeutics
      ALK-Abello
      Stallergenes Greer
      Laboratorios LETI
      ...

      Market segment by Type, the product can be split into
      Asthma
      Allergic Rhinitis
      Venom Allergy
      Food Allergy

      Market segment by Application, split into
      Hospital Pharmacies
      Online Pharmacies
      Retail Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Subcutaneous Immunotherapy status, future forecast, growth opportunity, key market and key players.
      To present the Subcutaneous Immunotherapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Subcutaneous Immunotherapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now